题名 | Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol: Two-Year Results. | 链接 | https://www.ncbi.nlm.nih.gov/pubmed/?term=26477842 |
https://www.ncbi.nlm.nih.gov/pubmed/?term=26477842 |